Delivery Order SPE2DB20D3103-SPE2DB22FP1A0
Award Date
7/5/22
Potential Completion Date
7/26/22
Potential Value
$27K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award, valued at $18,725.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. It is a firm-fixed-price delivery order contract with a completion date of December 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $6,803.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 100 mg Veklury (Remdesivir) vials. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and medical supplies for military healthcare programs. The contract has no set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (remdesivir) 100 mg vials. The contract, valued at $15,848.80, is a firm fixed-price delivery order that runs through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (remdesivir) 100 mg vials. The $13,618.40 firm fixed price contract has a period of performance through August 9, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3103|SPE2DB24FP6V0) worth $13,618.40 for the supply of 100 mg VEKLURY (Remdesivir) vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 16, 2024. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,754.64, is for the supply of Veklury (Remdesivir) 100 mg vials, a critical medication used to treat COVID-19. The contract is a firm fixed-price delivery order with a completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a $13,618.40 delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract runs through July 25, 2024 and was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $13,606.80 firm-fixed-price contract has an ultimate completion date of March 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a federal contract worth up to $1,361.84 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical...